Green Leaf Innovations Sponsored Post
It was stated that these other companies also seems to have announced that it selected Accent Clinical Research Professionals to administer these other companies first round of human research of its proprietary CB MDI.
According to some reports these other companies claim to be focused on manufacturing and marketing green leaf aerosol delivery systems based on pressurized Metered Dose Inhaler (MDI) technology. The said inhaler was believed to deliver measured amounts of green leaf directly into the systemic blood stream through the lungs with a short burst of aerosolized medicine.
Check the disclaimer on profile and landing page.